Dental Concerns of Hepatitis C

$10.00

Course Overview

Hepatitis C is a viral infection that primarily affects the liver but has significant systemic and oral health implications. With the advent of Direct-Acting Antivirals (DAAs), the landscape of Hepatitis C management has shifted from a chronic, often fatal condition to a curable one. However, millions remain undiagnosed or untreated. This course provides dental professionals with a comprehensive understanding of the Hepatitis C virus (HCV), its transmission pathways, and the critical importance of medical history evaluation in identifying at-risk patients.

The curriculum explores the specific dental concerns associated with HCV, including the management of patients with compromised liver function who may face bleeding risks or altered drug metabolism. Special attention is given to the oral manifestations of the disease, such as Oral Lichen Planus, Sjögren's-like syndrome, and sialadenitis, which often serve as early clinical indicators. Recognizing these signs allows the dental team to play a pivotal role in early diagnosis and interdisciplinary care.

Furthermore, this course reinforces the rigorous infection control protocols required to prevent transmission in the dental setting. It addresses the stigma often associated with the disease and empowers dental practitioners to provide safe, compassionate, and effective care. By understanding the intersection of liver health and oral health, clinicians can ensure better treatment outcomes and improve the quality of life for patients living with a history of Hepatitis C.

Learning Objectives

After completing this course, participants will be able to:

  • Describe the epidemiology, transmission modes, and risk factors associated with the Hepatitis C virus (HCV).
  • Explain the natural history of HCV infection, distinguishing between acute, chronic, and resolved stages.
  • Identify the common oral manifestations of Hepatitis C, including Oral Lichen Planus (OLP) and xerostomia.
  • Evaluate the impact of liver dysfunction on dental treatment planning, particularly regarding hemostasis and drug metabolism.
  • Discuss the mechanism and success rates of modern Direct-Acting Antiviral (DAA) therapies.
  • Recognize the extrahepatic manifestations of HCV that may influence overall patient health and dental care.
  • Implement standard infection control precautions to effectively prevent the occupational transmission of bloodborne pathogens.
  • Outline strategies for patient counseling and medical referral when Hepatitis C is suspected or disclosed.